Cargando…

Complement inhibition decreases early fibrogenic events in the lung of septic baboons

Acute respiratory distress syndrome (ARDS) induced by severe sepsis can trigger persistent inflammation and fibrosis. We have shown that experimental sepsis in baboons recapitulates ARDS progression in humans, including chronic inflammation and long-lasting fibrosis in the lung. Complement activatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Silasi-Mansat, Robert, Zhu, Hua, Georgescu, Constantin, Popescu, Narcis, Keshari, Ravi S, Peer, Glenn, Lupu, Cristina, Taylor, Fletcher B, Pereira, Heloise Anne, Kinasewitz, Gary, Lambris, John D, Lupu, Florea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627561/
https://www.ncbi.nlm.nih.gov/pubmed/26337158
http://dx.doi.org/10.1111/jcmm.12667
_version_ 1782398300432891904
author Silasi-Mansat, Robert
Zhu, Hua
Georgescu, Constantin
Popescu, Narcis
Keshari, Ravi S
Peer, Glenn
Lupu, Cristina
Taylor, Fletcher B
Pereira, Heloise Anne
Kinasewitz, Gary
Lambris, John D
Lupu, Florea
author_facet Silasi-Mansat, Robert
Zhu, Hua
Georgescu, Constantin
Popescu, Narcis
Keshari, Ravi S
Peer, Glenn
Lupu, Cristina
Taylor, Fletcher B
Pereira, Heloise Anne
Kinasewitz, Gary
Lambris, John D
Lupu, Florea
author_sort Silasi-Mansat, Robert
collection PubMed
description Acute respiratory distress syndrome (ARDS) induced by severe sepsis can trigger persistent inflammation and fibrosis. We have shown that experimental sepsis in baboons recapitulates ARDS progression in humans, including chronic inflammation and long-lasting fibrosis in the lung. Complement activation products may contribute to the fibroproliferative response, suggesting that complement inhibitors are potential therapeutic agents. We have been suggested that treatment of septic baboons with compstatin, a C3 convertase inhibitor protects against ARDS-induced fibroproliferation. Baboons challenged with 10(9) cfu/kg (LD50) live E. coli by intravenous infusion were treated or not with compstatin at the time of challenge or 5 hrs thereafter. Changes in the fibroproliferative response at 24 hrs post-challenge were analysed at both transcript and protein levels. Gene expression analysis showed that sepsis induced fibrotic responses in the lung as early as 24 hrs post-bacterial challenge. Immunochemical and biochemical analysis revealed enhanced collagen synthesis, induction of profibrotic factors and increased cell recruitment and proliferation. Specific inhibition of complement with compstatin down-regulated sepsis-induced fibrosis genes, including transforming growth factor-beta (TGF-β), connective tissue growth factor (CTGF), tissue inhibitor of metalloproteinase 1 (TIMP1), various collagens and chemokines responsible for fibrocyte recruitment (e.g. chemokine (C-C motif) ligand 2 (CCL2) and 12 (CCL12)). Compstatin decreased the accumulation of myofibroblasts and proliferating cells, reduced the production of fibrosis mediators (TGF-β, phospho-Smad-2 and CTGF) and inhibited collagen deposition. Our data demonstrate that complement inhibition effectively attenuates collagen deposition and fibrotic responses in the lung after severe sepsis. Inhibiting complement could prove an attractive strategy for preventing sepsis-induced fibrosis of the lung.
format Online
Article
Text
id pubmed-4627561
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-46275612015-11-05 Complement inhibition decreases early fibrogenic events in the lung of septic baboons Silasi-Mansat, Robert Zhu, Hua Georgescu, Constantin Popescu, Narcis Keshari, Ravi S Peer, Glenn Lupu, Cristina Taylor, Fletcher B Pereira, Heloise Anne Kinasewitz, Gary Lambris, John D Lupu, Florea J Cell Mol Med Original Articles Acute respiratory distress syndrome (ARDS) induced by severe sepsis can trigger persistent inflammation and fibrosis. We have shown that experimental sepsis in baboons recapitulates ARDS progression in humans, including chronic inflammation and long-lasting fibrosis in the lung. Complement activation products may contribute to the fibroproliferative response, suggesting that complement inhibitors are potential therapeutic agents. We have been suggested that treatment of septic baboons with compstatin, a C3 convertase inhibitor protects against ARDS-induced fibroproliferation. Baboons challenged with 10(9) cfu/kg (LD50) live E. coli by intravenous infusion were treated or not with compstatin at the time of challenge or 5 hrs thereafter. Changes in the fibroproliferative response at 24 hrs post-challenge were analysed at both transcript and protein levels. Gene expression analysis showed that sepsis induced fibrotic responses in the lung as early as 24 hrs post-bacterial challenge. Immunochemical and biochemical analysis revealed enhanced collagen synthesis, induction of profibrotic factors and increased cell recruitment and proliferation. Specific inhibition of complement with compstatin down-regulated sepsis-induced fibrosis genes, including transforming growth factor-beta (TGF-β), connective tissue growth factor (CTGF), tissue inhibitor of metalloproteinase 1 (TIMP1), various collagens and chemokines responsible for fibrocyte recruitment (e.g. chemokine (C-C motif) ligand 2 (CCL2) and 12 (CCL12)). Compstatin decreased the accumulation of myofibroblasts and proliferating cells, reduced the production of fibrosis mediators (TGF-β, phospho-Smad-2 and CTGF) and inhibited collagen deposition. Our data demonstrate that complement inhibition effectively attenuates collagen deposition and fibrotic responses in the lung after severe sepsis. Inhibiting complement could prove an attractive strategy for preventing sepsis-induced fibrosis of the lung. John Wiley & Sons, Ltd 2015-11 2015-09-03 /pmc/articles/PMC4627561/ /pubmed/26337158 http://dx.doi.org/10.1111/jcmm.12667 Text en © 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Silasi-Mansat, Robert
Zhu, Hua
Georgescu, Constantin
Popescu, Narcis
Keshari, Ravi S
Peer, Glenn
Lupu, Cristina
Taylor, Fletcher B
Pereira, Heloise Anne
Kinasewitz, Gary
Lambris, John D
Lupu, Florea
Complement inhibition decreases early fibrogenic events in the lung of septic baboons
title Complement inhibition decreases early fibrogenic events in the lung of septic baboons
title_full Complement inhibition decreases early fibrogenic events in the lung of septic baboons
title_fullStr Complement inhibition decreases early fibrogenic events in the lung of septic baboons
title_full_unstemmed Complement inhibition decreases early fibrogenic events in the lung of septic baboons
title_short Complement inhibition decreases early fibrogenic events in the lung of septic baboons
title_sort complement inhibition decreases early fibrogenic events in the lung of septic baboons
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627561/
https://www.ncbi.nlm.nih.gov/pubmed/26337158
http://dx.doi.org/10.1111/jcmm.12667
work_keys_str_mv AT silasimansatrobert complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT zhuhua complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT georgescuconstantin complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT popescunarcis complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT keshariravis complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT peerglenn complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT lupucristina complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT taylorfletcherb complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT pereiraheloiseanne complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT kinasewitzgary complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT lambrisjohnd complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons
AT lupuflorea complementinhibitiondecreasesearlyfibrogeniceventsinthelungofsepticbaboons